Skip to content
AwardedPOLGoods

Sukcesywne dostawy leków z programów lekowych typu B i typu C - PN/16/2026

Published
Published 24 April 2026
Deadline
Closed 14 May 2026

Overview

Wojewódzki Szpital Specjalistyczny im. Marii Skłodowskiej-Curie w Zgierzu procured successive deliveries of medications from type B and type C pharmaceutical programs, organized across 13 tasks covering programs such as C.37, B.29, B.70, C.45, B.126, C.43, and B.139. The contract, valued at 2,573,082.79 PLN, was awarded on 3 July 2026 to five suppliers: Centrala Farmaceutyczna Cefarm SA, Farmacol Logistyka Sp. z o.o, Komtur Polska Sp. z o.o, Roche Polska Sp. z o.o, and Urtica Sp. z o.o.

Key details

Country
POL
Status
Awarded
Category
Goods
Procedure
Open
Published
24 April 2026
Deadline
Closed
Classification (CPV)
Radio-isotopesPharmaceutical products

Award outcome

Awarded value
PLN 2,573,083
Award date
3 July 2026
Contract period
— → 21 December 2001
Winners
  • Centrala Farmaceutyczna Cefarm SA
  • Farmacol Logistyka Sp. z o.o
  • Komtur Polska Sp. z o. o
  • Roche Polska Sp. z o.o
  • Urtica Sp. z o.o

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    16 July 2026

  2. Contract Notice

    10 May 2026

  3. Contract Notice

    24 April 2026

Contracting authority

  • Wojewódzki Szpital Specjalistyczny im. Marii Skłodowskiej-Curie w Zgierzu

    Procuring entity

    Zgierz, POL

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Sukcesywne dostawy leków z programów lekowych typu B i typu C - PN/16/2026 — won by Centrala Farmaceutyczna Cefarm SA +4 — Skim